COMMUNIQUÉS West-GlobeNewswire

Prelude Therapeutics to Participate in the Chardan Healthcare Conference
16/10/2026
WILMINGTON, Del., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the [...]
4DMT Announces New Employment Inducement Grants
16/10/2026
EMERYVILLE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 2026
16/10/2026
PETACH TIKVA, Israel, Oct. 16, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an innovative medical imaging technology company, today provided a brief business update and [...]
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/10/2026
CAMBRIDGE, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA ® ) platform to [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/10/2026
WALTHAM, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
HealthRecon Connect Strengthens Compliance with Expanded ISO Certification Scope
16/10/2026
SOUTHLAKE, Texas, Oct. 16, 2026 (GLOBE NEWSWIRE) -- HealthRecon Connect, a technology-enabled Revenue Cycle Management solutions provider to U.S. healthcare organizations, today announced the successful completion of [...]
Kane Biotech Announces $250,000 Insider Loan
16/10/2026
Unsecured, non-interest-bearing loan provides additional working capital support WINNIPEG, Manitoba, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”), a [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
16/10/2026
PHILADELPHIA, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor [...]
Avicanna Transitions US Listing to OTCQB
16/10/2026
TORONTO, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
16/10/2026
BRISBANE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
Dr. Jacqueline Youtsos and ReNu Medical & Spa Congratulate Kasi Hudson on Becoming a Board Certified Dermatology Nurse Practitioner
16/10/2026
Advanced credential strengthens access to expert skin care for patients across Pittsburg, Southeast Kansas, and Southwest Missouri PITTSBURG, Kansas, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Dr. Jacqueline Youtsos, MD and the [...]
Natural Remedies' Bacomind Advances Research on Memory and Cognitive Health With New 600-Participant Study
16/10/2026
BANGALORE, India, Oct. 16, 2026 (GLOBE NEWSWIRE) -- As interest grows in memory, focus and mental sharpness throughout life, new clinical research is exploring the potential of a centuries-old botanical ingredient to [...]
Whole Lotta Dank Debuts Dank Pack Across Alberta, Announces Nationwide Search for Cannabis Partners
16/10/2026
Backed by eight retail locations and over 125,000 deliveries completed, Whole Lotta Dank launches its first cannabis brand, advances 20+ SKUs and seeks long-term partnerships with Canadian producers CALGARY, Alberta, [...]
Opus Genetics Announces FDA Approval of Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
16/10/2026
FDA expands the approved use of phentolamine ophthalmic solution 0.75% to include age-related near vision impairment, which affects millions of adults in the United States Approval supported by positive results from [...]
K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world
16/10/2026
K2 Vision has surpassed over 5,000 Light Adjustable Lens Procedures Seattle, WA, Oct. 16, 2026 (GLOBE NEWSWIRE) -- K2 Vision has performed 5,000 Light Adjustable Lens (LAL) procedures. RxSight, the company that makes [...]
Regulated information: Disclosure of a transparency notification from BlackRock, Inc.
16/10/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 16 October 2026 – 6 PM CET Disclosure of a transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure [...]
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease
16/10/2026
BOSTON, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
16/10/2026
Former Dermavant Chief Scientific Officer led development of tapinarof, the first FDA-approved AhR agonist, from mechanistic understanding through approval and commercialization Will lead AT177 through IND-enabling [...]
Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
16/10/2026
REMAIN-1 met its six-month co-primary endpoint with high statistical significance (p=0.0023; mITT population); demonstrated 80% retention of GLP-1 induced weight loss vs 67% for sham 32% of Revita ® participants in [...]

Pages